Monday, January 09, 2012

Risk-Sharing and Innovative Contracting Models for Bio/Pharmaceuticals (sponsor)

I am pleased to welcome CBI's 3rd Annual Risk-Sharing and Innovative Contracting Models for Bio/Pharmaceuticals conference as a Drug Channels sponsor. The conference will be held at the Doubletree Hotel in Philadelphia on March 22 and 23. Read more in the official description below or view the website.

I expect this to be another worthwhile event. Participating speakers come from such companies as Bristol-Myers Squibb, Generation Health, Johns Hopkins HealthCare, Premera Blue Cross, Prime Therapeutics, Savient Pharmaceuticals, and Shire.

CBI is offering a special $400 discount to Drug Channels readers. Just register with Promo code NGQ475. Thanks, CBI!


OFFICIAL DESCRIPTION

CBI’s 3rd Annual Risk-Sharing and Innovative Contracting Models provides an opportunity for updates and continued conversation on the strategic implications for pharma and biotech manufacturers when entering into risk-sharing agreements. Hear from elite industry experts from Bristol-Myers Squibb, John Hopkins Health Care, Dey Pharma, Shire and more.

Topics for 2012 include:

  • Identify updates within U.S. healthcare reform and how these initiatives can impact the marketplace and Pay-for-Performance
  • Determine which features from the European market can be adopted in the U.S.
  • Evaluate the Cigna/EMD Serono specialty agreement
  • Hear from key stakeholders on what they want when entering into a contractual agreement
  • Understand the key components of risk-sharing agreements and when/how to form one
  • Evaluate the legal and government reporting considerations surrounding a potential contract
  • Establish outcomes-based metrics to evaluate drug performance
 Check out the agenda and register today!

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...